Michael R. McMullen, Director of Bristol Myers Squibb BMY, has filed 0 purchases and 4 sales on the open market. The latest trade was on 03/31.

MM

MM

Michael R. McMullen

Director

Company

Bristol Myers Squibb BMY

First filing

23/07/26

Trades

32 trades

Buys / sales

0 / 4

12-month net buying

No record

Last trade

03/31

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Agilent TechnologiesA	Open-market sale10b5-1 plan	24/03/08	24/03/12	52,297 sh	$150.00	$7,844,550	−17.1%
Agilent TechnologiesA	Open-market sale10b5-1 plan	23/12/13	23/12/15	2,751 sh	$130.00	$357,630	−0.9%
Agilent TechnologiesA	Open-market sale10b5-1 plan	23/12/07	23/12/08	62,467 sh	$130.00	$8,120,710	−16.9%
Agilent TechnologiesA	Open-market sale10b5-1 plan	23/07/27	23/07/31	944 sh	$130.00	$122,720	−0.4%